![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4184 | |
A61P 35/00 |
(11) | Number of the document | 2131840 |
(13) | Kind of document | T |
(96) | European patent application number | 08724338.2 |
Date of filing the European patent application | 2008-03-07 | |
(97) | Date of publication of the European application | 2009-12-16 |
(45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/SG2008/000074 |
Date | 2008-03-07 |
(87) | Number | WO 2008/108741 |
Date | 2008-09-12 |
(30) | Number | Date | Country code |
905293 P | 2007-03-07 | US | |
905299 P | 2007-03-07 | US |
(72) |
GOH, Kay Lin, SG
KHNG, Hwee Hoon, SG
SABANAYAGAM, Vasantha, Malar, MY
SANGTHONGPITAQ, Kanda, SG
STUNKEL, Walter, SG
TAN, Yong Cheng, SG
WOOD, Jeanette Marjorie, SG
|
(73) |
MEI Pharma, Inc.,
3611 Valley Centre Drive, Suite 500, San Diego, CA 92130,
US
|
(54) | COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT |
COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT |